| 04-08-2025 | PM |  | IDXX | IDEXX Laboratories, Inc. | 42,970 | 3.63 | 3.31 | 2.44 | IDEXX Laboratories Non-GAAP EPS of $3.50 beats by $0.20, revenue of $1.11B beats by $40M [8/4/2025 6:34 AM]
 | 683.83 | 148.29 (27.69%)
 | 640.08 | 104.54 (19.52%)
 | 356.14 - 688.12 | 3,025,089 | 720,000 | 29,218 |  | 
            
                |  | 
        
            | 01-05-2025 | PM |  | IDXX | IDEXX Laboratories, Inc. | 35,540 | 2.96 | 2.92 | 2.81 | IDEXX Laboratories beats top-line and bottom-line estimates; updates FY25 outlook [5/1/2025 6:38 AM]
 | 471.47 | 38.82 (8.97%)
 | 444.50 | 11.85 (2.74%)
 | 356.14 - 548.88 | 1,164,816 | 950,000 | 3,323 |  | 
            
                |  | 
        
            | 03-02-2025 | PM |  | IDXX | IDEXX Laboratories, Inc. | 34,720 | 2.62 | 2.40 | 2.32 | IDEXX Laboratories GAAP EPS of $2.62 beats by $0.22, revenue of $954M beats by $17.32M [2/3/2025 6:32 AM]
 | 469.54 | 47.49 (11.25%)
 | 460.00 | 37.95 (8.99%)
 | 398.50 - 583.39 | 1,202,792 | 870,000 | 10,049 |  | 
            
                |  | 
        
            | 31-10-2024 | PM |  | IDXX | IDEXX Laboratories, Inc. | 36,860 | 2.80 | 2.69 | 2.53 | IDEXX Laboratories Non-GAAP EPS of $2.79 beats by $0.10, revenue of $975.54M misses by $5.42M [10/31/2024 6:32 AM]
 | 408.83 | -42.25 (-9.37%)
 | 433.56 | -17.52 (-3.88%)
 | 372.50 - 583.39 | 1,765,729 | 690,000 | 841 |  | 
            
                |  | 
        
            | 06-08-2024 | PM |  | IDXX | IDEXX Laboratories, Inc. | 39,460 | 2.44 | 2.87 | 2.67 | IDEXX Laboratories beats top-line and bottom-line estimates; narrows FY24 outlook [8/6/2024 6:33 AM]
 | 469.37 | 14.29 (3.14%)
 | 469.37 | 0.0 (0.00%)
 | 372.50 - 583.39 | 1,072,060 | 660,000 | 5,494 |  | 
            
                |  | 
        
            | 01-05-2024 | PM |  | IDXX | IDEXX Laboratories, Inc. | 41,990 | 2.81 | 2.68 | 2.55 | IDEXX Laboratories reports mixed Q1 results; updates FY24 outlook [5/1/2024 6:33 AM]
 | 468.54 | -24.22 (-4.92%)
 | 492.76 | 0.0 (0.00%)
 | 372.50 - 583.39 | 836,760 | 500,000 | 2,194 |  | 
            
                |  | 
        
            | 05-02-2024 | PM |  | IDXX | IDEXX Laboratories, Inc. | 43,790 | 2.32 | 2.12 | 2.05 | IDEXX Laboratories beats top-line and bottom-line estimates; initiates FY24 outlook [2/5/2024 6:34 AM]
 | 572.70 | 45.56 (8.64%)
 | 530.00 | 2.86 (0.54%)
 | 372.50 - 573.62 | 777,647 | 410,000 | 7,639 |  | 
            
                |  | 
        
            | 01-11-2023 | PM |  | IDXX | IDEXX Laboratories, Inc. | 32,910 | 2.53 | 2.37 | 2.15 | IDEXX Laboratories GAAP EPS of $2.53 beats by $0.16, revenue of $916M misses by $11.31M [11/1/2023 6:36 AM]
 | 395.06 | -4.41 (-1.10%)
 | 375.00 | -24.47 (-6.13%)
 | 354.81 - 564.73 | 1,303,247 | 510,000 | 1,972 |  | 
            
                |  | 
        
            | 01-08-2023 | PM |  | IDXX | IDEXX Laboratories, Inc. | 45,880 | 2.67 | 2.43 | 1.56 | IDEXX Laboratories Non-GAAP EPS of $2.70 beats by $0.23, revenue of $943.63M beats by $9.58M [8/1/2023 6:33 AM]
 | 532.18 | -22.55 (-4.07%)
 | 543.00 | -11.73 (-2.11%)
 | 317.06 - 564.73 | 556,634 | 550,000 | 2,172 |  | 
            
                |  | 
        
            | 02-05-2023 | PM | 6:30 AM ET (May 2)
 | IDXX | IDEXX Laboratories, Inc. | 40,210 | 2.55 | 2.39 | 2.27 | IDEXX Laboratories GAAP EPS of $2.55 beats by $0.17, revenue of $900M beats by $9.4M [5/2/2023 6:33 AM]
 | 467.46 | -22.14 (-4.52%)
 | 482.00 | -7.60 (-1.55%)
 | 317.06 - 515.79 | 526,607 | 350,000 | 1,993 |  | 
            
                |  | 
        
            | 06-02-2023 | PM | 6:30 AM ET (Feb 6)
 | IDXX | IDEXX Laboratories, Inc. | 41,760 | 2.05 | 1.92 | 1.89 | IDEXX Laboratories Non-GAAP EPS of $2.07 beats by $0.15, revenue of $828.57M beats by $7.66M, initiates 2023 guidance [2/6/2023 6:32 AM]
 | 485.41 | 3.00 (0.62%)
 | 495.93 | 13.52 (2.80%)
 | 317.06 - 560.92 | 868,724 | 650,000 | 10,565 |  | 
            
                |  | 
        
            | 01-11-2022 | PM | 6:30 AM ET (Nov 1)
 | IDXX | IDEXX Laboratories, Inc. | 30,330 | 2.15 | 2.04 | 2.03 | IDEXX Laboratories Non-GAAP EPS of $2.23 beats by $0.19, revenue of $841.66M beats by $11.66M [11/1/2022 6:34 AM]
 | 395.21 | 35.53 (9.88%)
 | 370.00 | 10.32 (2.87%)
 | 317.06 - 670.92 | 832,999 | 450,000 | 1,408 |  | 
            
                |  | 
        
            | 02-08-2022 | PM | 6:30 AM ET (Aug 2)
 | IDXX | IDEXX Laboratories, Inc. | 33,060 | 1.56 | 1.55 | 2.34 | IDEXX Laboratories Non-GAAP EPS of $1.58 misses by $0.05, revenue of $860.55M misses by $1.57M [8/2/2022 6:35 AM]
 | 400.07 | 1.94 (0.49%)
 | 387.00 | -11.13 (-2.80%)
 | 318.50 - 706.51 | 983,254 | 600,000 | 805 |  | 
            
                |  | 
        
            | 04-05-2022 | PM | 6:30 AM ET (May 4)
 | IDXX | IDEXX Laboratories | 36,268 | 2.27 | 2.25 | 0.00 | IDEXX Laboratories Non-GAAP EPS of $2.24 misses by $0.01, revenue of $836.54M in-line [5/4/2022 6:35 AM]
 | 410.54 | -25.42 (-5.83%)
 | 382.00 | -53.96 (-12.38%)
 | 381.11 - 706.95 | 1,780,112 | 680,000 | 54,717 |  | 
            
                |  | 
        
            | 02-02-2022 | PM | 6:30 AM ET (Feb 2)
 | IDXX | IDEXX Laboratories, Inc. | 41,470 | 1.89 | 1.67 | 2.01 | IDEXX Laboratories GAAP EPS of $1.89 beats by $0.20, revenue of $801M beats by $19.17M; issues full year guidance [2/2/2022 6:33 AM]
 | 534.76 | 21.25 (4.14%)
 | 535.00 | 21.49 (4.18%)
 | 460.36 - 706.95 | 868,219 | 680,000 | 8,351 |  | 
            
                |  | 
        
            | 02-11-2021 | PM | 6:30 AM ET (Nov 2)
 | IDXX | IDEXX Laboratories, Inc. | 444,450 | 2.03 | 1.88 | 1.69 | IDEXX Laboratories EPS beats by $0.05, beats on revenue [11/2/2021 6:34 AM]
 | 627.35 | -39.13 (-5.87%)
 | 627.35 | 0.0 (0.00%)
 | 421.15 - 706.95 | 710,010 | 270,000 | 6,696 |  | 
            
                |  | 
        
            | 30-07-2021 | PM | 6:30 AM ET (Jul 30)
 | IDXX | IDEXX Laboratories, Inc. | 59,320 | 2.34 | 2.01 | 1.72 | IDEXX Laboratories EPS beats by $0.23, beats on revenue, raises guidance [7/30/2021 6:34 AM]
 | 678.86 | -25.30 (-3.59%)
 | 674.87 | -29.29 (-4.16%)
 | 347.54 - 706.95 | 608,970 | 350,000 | 2,088 |  | 
            
                |  | 
        
            | 04-05-2021 | PM | 6:30 AM ET (May 4)
 | IDXX | IDEXX Laboratories, Inc. | 47,320 | 2.35 | 1.72 | 1.29 | IDEXX Laboratories EPS beats by $0.64, beats on revenue; raises FY 2021 outlook [5/4/2021 6:33 AM]
 | 526.88 | -23.00 (-4.18%)
 | 526.88 | 0.0 (0.00%)
 | 266.00 - 573.99 | 574,887 | 310,000 | 8,372 |  | 
            
                |  | 
        
            | 02-02-2021 | PM | 6:30 AM ET (Feb 2)
 | IDXX | IDEXX Laboratories, Inc. | 40,830 | 2.01 | 1.43 | 1.04 | IDEXX Laboratories EPS beats by $0.23, beats on revenue [2/2/2021 6:32 AM]
 | 507.29 | 14.87 (3.02%)
 | 501.00 | 8.58 (1.74%)
 | 168.65 - 522.90 | 591,834 | 403,671 | 2,502 |  | 
            
                |  | 
        
            | 29-10-2020 | PM | 6:30 AM ET (Oct 29)
 | IDXX | IDEXX Laboratories, Inc. | 37,690 | 1.69 | 1.42 | 1.24 | IDEXX Laboratories EPS beats by $0.31, beats on revenue [10/29/2020 6:37 AM]
 | 441.80 | 18.91 (4.47%)
 | 434.00 | 11.11 (2.63%)
 | 168.65 - 453.20 | 546,097 | 321,280 | 1,560 |  | 
            
                |  | 
        
            | 31-07-2020 | PM | 6:30 AM ET (Jul 31)
 | IDXX | IDEXX Laboratories, Inc. | 31,160 | 1.72 | 1.19 | 1.43 | IDEXX Laboratories EPS beats by $0.54, beats on revenue [7/31/2020 6:32 AM]
 | 391.38 | 17.28 (4.62%)
 | 386.19 | 12.09 (3.23%)
 | 168.65 - 407.86 | 337,269 | 363,397 | 1,710 |  | 
            
                |  |